Sainsbury’s boss has warned that regulators could force Britain’s second-largest supermarket to pull out of its proposed merger with rival Asda.
Last month, the Competition and Markets Authority (CMA) kicked off a formal investigation into the merger amid concerns over the potential for higher prices and worse quality of service. Both Sainsbury’s and Asda have asked the CMA to fast-track the investigation into the more in-depth phase 2 stage, something which could be announced as early as this week.
Sainsbury’s CEO Mike Coupe has said there are some “extreme scenarios” where the remedies demanded by regulators might render any deal pointless.
“There is an Ebitda [earnings before interest, tax, depreciation, and amortisation] threshold at which point either party has the right to walk away,” he told the Financial Times. “It’s not a number of stores, it’s a level of profitability.”
Sainsbury’s has previously stated the combined group will benefit from buying produce at the lowest price each company pays. However, it has not disclosed how much this gross cost saving will be worth.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas